Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER+/HER2- breast cancer: a randomised phase 2 trial
Abstract
Source data and R code to recreate the figures of the manuscript.
Publication details
- Journal / source
- Figshare
- Publication date
- 26 June 2026
- Document type
- Dataset